Table 3.
Scleroderma Utilities
| Health State | Number of respondents | Mean | SD |
|---|---|---|---|
| Mild SSc | |||
| RS | 94 | 69.7 | 15.3 |
| TTO | 94 | 0.80 | 0.25 |
| SG | 94 | 0.81 | 0.26 |
| Moderate SSc | |||
| RS | 172 | 54.9 | 15.8 |
| TTO | 172 | 0.68 | 0.28 |
| SG | 172 | 0.76 | 0.27 |
| Moderate SSc with lung involvement | |||
| RS | 177 | 45.3 | 15.5 |
| TTO | 177 | 0.59 | 0.3 |
| SG | 177 | 0.68 | 0.28 |
| Severe SSc | |||
| RS | 120 | 30 | 16.3 |
| TTO | 120 | 0.37 | 0.29 |
| SG | 120 | 0.50 | 0.31 |
| Severe SSc with lung involvement | |||
| RS | 90 | 25.3 | 15.2 |
| TTO | 90 | 0.36 | 0.31 |
| SG | 90 | 0.51 | 0.32 |
SD: standard deviation; PsA: psoriatic arthritis; RS: rating scale (range: 0-100); TTO: time tradeoff (range: 0.0-1.0); SG: standard gamble (range: 0.0-1.0).